LDL-C combined with Chinese visceral adiposity index as a risk stratification tool for cardiometabolic multimorbidity in middle-aged and older Chinese adults: a national prospective cohort study
A two-part blood test combining cholesterol and belly-fat measures identifies cardiometabolic disease risk better than either alone in Chinese adults.
This national prospective Chinese cohort validates a combined LDL-C + Chinese visceral adiposity index composite for cardiometabolic multimorbidity risk stratification, showing improved risk prediction over single biomarkers. The composite tool may enable earlier identification of high-risk individuals for preventive interventions in Chinese adults.
What the study was
- Study design
- Prospective cohort study (national registry-linked)
- Population
- Middle-aged and older Chinese adults
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Cardiovascular Diabetology
Why it surfaced
Composite cardiometabolic risk tool validation in Chinese national cohort; near-term implementable in Asian clinical settings.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.